DK0765333T3 - Quillajasaponinadjuvans og vaccineformulering, der indeholder denne - Google Patents

Quillajasaponinadjuvans og vaccineformulering, der indeholder denne

Info

Publication number
DK0765333T3
DK0765333T3 DK96909390T DK96909390T DK0765333T3 DK 0765333 T3 DK0765333 T3 DK 0765333T3 DK 96909390 T DK96909390 T DK 96909390T DK 96909390 T DK96909390 T DK 96909390T DK 0765333 T3 DK0765333 T3 DK 0765333T3
Authority
DK
Denmark
Prior art keywords
formulation containing
vaccine formulation
quillajasaponin
adjuvant
quillajasaponin adjuvant
Prior art date
Application number
DK96909390T
Other languages
English (en)
Inventor
Hye-Sung Yoon
Hong-Seob So
Young-Sun Kwon
Joong-Myung Cho
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Application granted granted Critical
Publication of DK0765333T3 publication Critical patent/DK0765333T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96909390T 1995-04-13 1996-04-12 Quillajasaponinadjuvans og vaccineformulering, der indeholder denne DK0765333T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19950008590 1995-04-13
KR19950008589 1995-04-13
PCT/KR1996/000053 WO1996032401A1 (en) 1995-04-13 1996-04-12 Quillaja saponin adjuvant and vaccine formulation containing same

Publications (1)

Publication Number Publication Date
DK0765333T3 true DK0765333T3 (da) 2000-03-13

Family

ID=37027969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909390T DK0765333T3 (da) 1995-04-13 1996-04-12 Quillajasaponinadjuvans og vaccineformulering, der indeholder denne

Country Status (16)

Country Link
US (1) US5817314A (da)
EP (1) EP0765333B1 (da)
JP (1) JP2761809B2 (da)
KR (1) KR0184779B1 (da)
CN (2) CN1044478C (da)
AR (1) AR001618A1 (da)
AT (1) ATE186541T1 (da)
AU (1) AU678941B2 (da)
BR (1) BR9606311A (da)
CA (1) CA2190344C (da)
DE (1) DE69605094T2 (da)
DK (1) DK0765333T3 (da)
ES (1) ES2140837T3 (da)
MX (1) MX9601378A (da)
TW (1) TW442293B (da)
WO (1) WO1996032401A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
EP1009429B1 (en) * 1997-08-29 2009-07-08 Antigenics Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
US6262029B1 (en) 1998-08-14 2001-07-17 Galenica Pharmaceuticals, Inc. Chemically modified saponins and the use thereof as adjuvants
TW586935B (en) * 1998-09-14 2004-05-11 Kitasato Inst Saponin-containing vaccine preparation
DE69935606T9 (de) * 1998-10-16 2021-03-11 Glaxosmithkline Biologicals S.A. Adjuvanzsysteme und impfstoffe
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
AU2243801A (en) * 1999-12-08 2001-06-18 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminium salt
US8883170B2 (en) * 2008-09-03 2014-11-11 Western Illinois University Research Foundation Adjuvant
EP2359698B1 (en) 2010-01-22 2013-12-04 Symrise AG Compositions with a surfactant system comprising saponins, and lecithin
EP2359702B1 (en) 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
KR20140019307A (ko) 2010-12-09 2014-02-14 와이앤드비 마더스 초이스 엘티디. 사포닌을 포함하는 제형 및 이의 용도
DK2648809T3 (da) 2010-12-09 2019-07-15 Y&B Mothers Choice Ltd Naturlige formuleringer
EP2628398B1 (de) 2012-02-19 2016-09-07 Symrise AG Stoffgemische
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105213471A (zh) * 2014-05-29 2016-01-06 江口县苗药生物科技有限公司 一种皂树皮总皂苷的提取工艺
WO2019106191A1 (en) * 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin extraction
EP3717001A1 (en) 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponin purification
TWI820099B (zh) * 2018-03-28 2023-11-01 台灣浩鼎生技股份有限公司 新穎皂素佐劑及其評估方法
CN116355035B (zh) * 2021-12-28 2024-03-12 成都迈科康生物科技有限公司 一种qs21免疫佐剂的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA2158651C (en) * 1993-03-29 2009-09-01 David S. Roberts Multicomponent clostridial vaccines using saponin adjuvants

Also Published As

Publication number Publication date
EP0765333B1 (en) 1999-11-10
KR0184779B1 (ko) 1999-04-01
CA2190344A1 (en) 1996-10-16
CN1262958A (zh) 2000-08-16
JPH09510740A (ja) 1997-10-28
EP0765333A1 (en) 1997-04-02
CN1044478C (zh) 1999-08-04
JP2761809B2 (ja) 1998-06-04
CA2190344C (en) 2001-04-10
US5817314A (en) 1998-10-06
BR9606311A (pt) 1997-09-16
AU678941B2 (en) 1997-06-12
AR001618A1 (es) 1997-11-26
CN1149875A (zh) 1997-05-14
DE69605094D1 (de) 1999-12-16
ES2140837T3 (es) 2000-03-01
KR960037694A (ko) 1996-11-19
WO1996032401A1 (en) 1996-10-17
ATE186541T1 (de) 1999-11-15
MX9601378A (es) 1997-04-30
DE69605094T2 (de) 2000-07-06
TW442293B (en) 2001-06-23
AU5290096A (en) 1996-10-30

Similar Documents

Publication Publication Date Title
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
DK1035865T3 (da) HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
NO20003302L (no) Vaksine
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
KR900011476A (ko) 백신 제제
DZ2055A1 (fr) Compositions vaccinantes.
DK1126876T3 (da) Adjuvanssystemer og vacciner
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
FR2601370B1 (fr) Vaccin contre le melanome.
NO932915D0 (no) Mikroporoest krystallinsk silikoaluminofosfat og fremgangsmaate for fremstilling av dette
DZ2283A1 (fr) Composition de vaccin.
NO995324L (no) Baerer for gjenstander og emne for denne
NO993731D0 (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
NO965023L (no) Maltitolblanding og fremstilling derav
FI973362A (fi) Transdermaalinen formula
NO991771D0 (no) Sprengstoff-formuleringer
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
ATE253641T1 (de) Antigenische präparationen
NO924974D0 (no) Partikkelformig, opasitetsbevirkende ekstender for matrikser og anvendelse av denne
NO985079D0 (no) Eksplosiv formulering
OA08478A (fr) Vaccin contre la mélanome.
NO985110D0 (no) Eksplosivformuleringer